Endometrics key facts
- Operator of a women's health company intended to develop a non-invasive diagnostic test for endometriosis.
- It has raised $250K; the latest was Accelerator/Incubator ($50K) in Feb 2026.
- Notable investors include MassChallenge, Berkeley SkyDeck, First Spark Ventures, Granatus Ventures, Blue Cross Blue Shield of Massachusetts — 7 tracked in total.
- Status: Privately Held (backing).
- ·Watch Endometrics: the Monday email on marks, rounds and moves
Endometrics funding rounds
No funding rounds for Endometrics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Endometrics investors
7 investors are on record for Endometrics, including MassChallenge, Berkeley SkyDeck, First Spark Ventures and Granatus Ventures.
About Endometrics
Operator of a women's health company intended to develop a non-invasive diagnostic test for endometriosis. The company's technology facilitates medical tests that include at-home menstrual blood collection and subsequent laboratory analysis, enabling women to overcome chronic pain associated with endometriosis.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2021
- Employees
- 5
- Website
- endometrics.us/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Endometrics doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.